GLP-1 Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials
4 weeks ago
1
ARTICLE AD BOX
The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases.